Recently, Subramanian et al., by employing the dual γ/δ inhibitor CAL-130, proposed the predominant role of p110γ and p110δ in PTEN deleted T-ALL, suggesting the possibility to target this malignancy by inhibiting specifically these isoforms [14]. Here, PTEN is linked to acute lymphoblastic leukemia.